Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy-Reference-Cited by-同舟云学术

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy

Published:2014-11-13 Issue:17 Volume:28 Page:2531-2539
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Blanco José L.,Montaner Julio S.G.,Marconi Vincent C.,Santoro Maria M.,Campos-Loza Ariel E.,Shafer Robert W.,Miller Michael D.,Paredes Roger,Harrigan Richard,Nguyen Mihn L.,Perno Carlo F.,Gonzalez-Hernandez Lucero A.,Gatell José M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference25 articles.

1. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention.;Chesney;J Acquir Immune Defic Syndr,2006

2. Simpler regimens may enhance adherence to antiretrovirals in HIV infected patients.;Maggiolo;HIV Clin Trials,2002

3. Perspectives on adherence and simplicity of HIV-infected patients on antiretroviral therapy. Self-report of the relative importance of multiple attributes of Highly Active Antiretroviral Therapy (HAART) regimens in predicting adherence.;Stone;J Acquir Immune Defic Syndr,2004

4. Combination therapy in hypertension.;Gradman;J Am Soc Hypertens,2010

5. Fixed-dose combinations of antituberculous medications to prevent drug resistance.;Moulding;Ann Intern Med,1995

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004–2021;The Journal of Infectious Diseases;2024-07-23

2. Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2024-05-17

3. A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation;Pharmaceutics;2022-12-25

4. Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control;The Lancet Infectious Diseases;2022-11

5. The Prevalence and Related Effects of HIV Drug-Resistant Strains Against Antiretroviral Therapy in China;Infectious Microbes and Diseases;2022-05-17